Evidence map›Paper›PMID 25342755›Full record

ArticleThe Journal of biological chemistry2014

Decreasing mitochondrial fission prevents cholestatic liver injury.

Tianzheng Yu, Li Wang, Hakjoo Lee, Dawn K O'Brien, Steven F Bronk, Gregory J Gores, Yisang Yoon

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review: Pathogenesis of cholestatic liver diseases.World journal of hepatology · 2020
    Review
  10. Hepatic alterations during the development and progression of cancer cachexia.Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Tianzheng YuFrom the Department of Physiology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912 and.
Li WangFrom the Department of Physiology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912 and.
Hakjoo LeeFrom the Department of Physiology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912 and.
Dawn K O'BrienFrom the Department of Physiology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912 and.
Steven F BronkDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905.
Gregory J GoresDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905.
Yisang YoonFrom the Department of Physiology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912 and yyoon@gru.edu.
Mayo Clinic · USWinnMed · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
MECHANISMS OF LIVER CELL INJURYR01DK041876 · NIDDK · MAYO CLINIC ROCHESTER · PI GORES, GREGORY J. · 1992 to 2019
$3.6M
MECHANISMS OF LIVER CELL INJURYR37DK041876 · NIDDK · MAYO CLINIC ROCHESTER · PI GORES, GREGORY J. · 2000 to 2009
$2.9M
Regulation of Mitochondrial Morphology in Liver CellsR01DK061991 · NIDDK · UNIVERSITY OF ROCHESTER · PI YOON, YISANG · 2003 to 2013
$2.2M
INTRACELLULAR PH IN LIVER CELL INJURYR29DK041876 · NIDDK · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI GORES, GREGORY J. · 1989 to 1992
–
NIDDK NIH HHS DK061991NIDDK NIH HHS DK41876NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK041876NIDDK NIH HHS R01 DK061991NIDDK NIH HHS R37 DK041876
6 · The paper itself

Abstract

Mitochondria frequently change their shape through fission and fusion in response to physiological stimuli as well as pathological insults. Disrupted mitochondrial morphology has been observed in cholestatic liver disease. However, the role of mitochondrial shape change in cholestasis is not defined. In this study, using in vitro and in vivo models of bile acid-induced liver injury, we investigated the contribution of mitochondrial morphology to the pathogenesis of cholestatic liver disease. We found that the toxic bile salt glycochenodeoxycholate (GCDC) rapidly fragmented mitochondria, both in primary mouse hepatocytes and in the bile transporter-expressing hepatic cell line McNtcp.24, leading to a significant increase in cell death. GCDC-induced mitochondrial fragmentation was associated with an increase in reactive oxygen species (ROS) levels. We found that preventing mitochondrial fragmentation in GCDC by inhibiting mitochondrial fission significantly decreased not only ROS levels but also cell death. We also induced cholestasis in mouse livers via common bile duct ligation. Using a transgenic mouse model inducibly expressing a dominant-negative fission mutant specifically in the liver, we demonstrated that decreasing mitochondrial fission substantially diminished ROS levels, liver injury, and fibrosis under cholestatic conditions. Taken together, our results provide new evidence that controlling mitochondrial fission is an effective strategy for ameliorating cholestatic liver injury.

Indexed as

MutationAdenoviridaeAnimalsCell DeathCell LineCholestasisCommon Bile DuctDynaminsGene ExpressionGenetic VectorsGlycochenodeoxycholic AcidGreen Fluorescent ProteinsHepatocytesLiverLiver CirrhosisMaleDnm1l protein, mouseDynaminsenhanced green fluorescent proteinGlycochenodeoxycholic AcidGreen Fluorescent ProteinsReactive Oxygen SpeciesBile AcidCell DeathCholestasisDLP1Drp1LiverMitochondriaMitochondrial FissionMitochondrial FusionReactive Oxygen Species (ROS)

Identifiers

PMID25342755
PMCPMC4256342
OpenAlexW2048919885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.